S 3325119th CongressIn Committee
Expanding Access to Affordable Drugs and Medical Devices Act
Standard Summary
Balanced plain-English summary
This bill would amend the Internal Revenue Code to create rules for determining the tax-exempt status of organizations that manufacture or distribute drugs and medical devices to meet public health needs. It would allow qualifying organizations to be designated as public interest drug or medical device health care organizations, set eligibility and governance requirements, define eligible drugs and devices, and impose excess-benefit rules on certain funding.
Key Points
- 1Creates a new tax-exempt designation for public interest drug or medical device health care organizations.
- 2Requires organizations to focus on making eligible drugs or devices affordable and to meet U.S. organization, control, and board-governance requirements.
- 3Defines eligible drugs and devices by factors such as shortages, cost reductions, unmet health needs, and public health or emergency supply needs.
- 4Requires designated organizations to give the government priority access to certain products for the strategic national stockpile under specified conditions.
- 5Adds excess-benefit tax rules for impermissible funding of designated organizations.
Impact Areas
Tax-exempt health care organizationsDrug and medical device manufacturers and distributorsPatients and consumersFederal tax administrationPublic health supply chains
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026